These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 10747765)

  • 1. Use and cost of hospital and community service provision for children with HIV infection at an English HIV referral centre.
    Beck EJ; Mandalia S; Griffith R; Beecham J; Walters MD; Boulton M; Miller DL
    Pharmacoeconomics; 2000 Jan; 17(1):53-69. PubMed ID: 10747765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use and cost of HIV service provision in England in 1996. National Prospective Monitoring System (NPMS) Steering Group and NPMS Working Party on Costs.
    Beck EJ; Tolley K; Power A; Mandalia S; Rutter P; Izumi J; Beecham J; Gray A; Barlow D; Easterbrook P; Fisher M; Innes J; Kinghorn G; Mandel B; Pozniak A; Tang A; Tomlinson D; Williams I
    Pharmacoeconomics; 1998 Dec; 14(6):639-52. PubMed ID: 10346416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing use of hospital services and costs at a London AIDS referral centre, 1983-1989.
    Beck EJ; Kennelly J; McKevitt C; Whitaker L; Wadsworth J; Miller DL; Easmon C; Pinching AJ; Harris JR
    AIDS; 1994 Mar; 8(3):367-77. PubMed ID: 8031516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital service utilization by HIV/AIDS patients and their management cost in a provincial genitourinary medicine department.
    Nageswaran A; Kinghorn GR; Shen RN; Priestley CJ; Kyi TT
    Int J STD AIDS; 1995; 6(5):336-44. PubMed ID: 8547414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financing HIV service provision in England: estimated impact of the cost of antiretroviral combination therapy.
    Beck EJ; Tolley K
    Int J STD AIDS; 1998 Sep; 9(9):512-7. PubMed ID: 9764934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic costs of caring for people with HIV infection and AIDS in England and Wales.
    Petrou S; Dooley M; Whitaker L; Beck E; Kupek E; Wadsworth J; Miller D; Renton A
    Pharmacoeconomics; 1996 Apr; 9(4):332-40. PubMed ID: 10160107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost and utilisation of community services for people with HIV infection in London.
    Petrou S; Dooley M; Whitaker L; Beck E; Kupek E; Wadsworth J; Miller D; Renton A
    Health Trends; 1995; 27(2):62-8. PubMed ID: 10153161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the cost of getting the price wrong?
    Beck EJ; Beecham J; Mandalia S; Griffith R; Walters MD; Boulton M; Miller DL
    J Public Health Med; 1999 Sep; 21(3):311-7. PubMed ID: 10528959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing cost of English HIV service provision 1996-1997. NPMS Steering Group. National Prospective Monitoring System.
    Int J STD AIDS; 1999 Jun; 10(6):357-62. PubMed ID: 10414877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use and cost of hospital services by London AIDS patients with different AIDS defining conditions.
    Beck EJ; Kupek EJ; Wadsworth J; Miller DL; Pinching AJ; Harris JR
    J Public Health Med; 1996 Dec; 18(4):457-64. PubMed ID: 9023806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The costs of treating HIV-infected children in Abidjan, Ivory Coast, 1996-1997].
    Giraudon I; Leroy V; Msellati P; Elenga N; Ramon R; Welffens-Ekra C; Dabis F
    Sante; 1999; 9(5):277-81. PubMed ID: 10657769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demograghic and socio-economic determinants of community and hospital services costs for people with HIV/AIDS in London.
    Kupek E; Dooley M; Whitaker L; Petrou S; Renton A
    Soc Sci Med; 1999 May; 48(10):1433-40. PubMed ID: 10369442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing presentation and survival, service utilization and costs for AIDS patients: insights from a London referral centre.
    Beck EJ; Whitaker L; Kennelly J; McKevitt C; Wadsworth J; Miller DL; Easmon C; Pinching AJ; Harris JR
    AIDS; 1994 Mar; 8(3):379-84. PubMed ID: 8031517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective evaluation of the cost effectiveness of adding lamivudine to zidovudine-containing antiretroviral treatment regimens in HIV infection. European perspective.
    Lacey L; Youle M; Trueman P; Staszewski S; Schrappe M; Behrens M
    Pharmacoeconomics; 1999; 15 Suppl 1():39-53. PubMed ID: 10537441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resource utilization and direct costs of pediatric HIV in Italy.
    Giacomet V; Fabiano V; Lo Muto R; Caiazzo MA; Curto A; Rampon O; Zuccotti GV; Garattini L
    AIDS Care; 2013; 25(11):1392-8. PubMed ID: 23414422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical resource utilization and cost of HIV-related care in the highly active antiretroviral therapy era at a University Clinic in Sweden.
    Ghatnekar O; Hjortsberg C; Gisslén M; Lindbäck S; Löthgren M
    Pharmacoeconomics; 2010; 28 Suppl 1():49-57. PubMed ID: 21182343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic implications of multiple births: inpatient hospital costs in the first 5 years of life.
    Henderson J; Hockley C; Petrou S; Goldacre M; Davidson L
    Arch Dis Child Fetal Neonatal Ed; 2004 Nov; 89(6):F542-5. PubMed ID: 15499151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the utilization of health services and costs of hospital-based medical care for 29 patients with HIV/AIDS in China].
    Yang HM; Li J; Wu ZY; Xu LZ; Wang KA
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 May; 24(5):393-6. PubMed ID: 12820935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost effectiveness of combination antiretroviral therapy for HIV disease.
    Freedberg KA; Losina E; Weinstein MC; Paltiel AD; Cohen CJ; Seage GR; Craven DE; Zhang H; Kimmel AD; Goldie SJ
    N Engl J Med; 2001 Mar; 344(11):824-31. PubMed ID: 11248160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-acute care for older people in community hospitals--a cost-effectiveness analysis within a multi-centre randomised controlled trial.
    O'Reilly J; Lowson K; Green J; Young JB; Forster A
    Age Ageing; 2008 Sep; 37(5):513-20. PubMed ID: 18515290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.